None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Among all adult (>=18years) patients with Staphylococcus aureus bacteremia at participating hospital during the study period 1) Patients who agree to the gathering clinical information about S. aureus bacteremia by means of an informed consent. 2) Patients who fulfill the criteria of a waiver: Patients who died or transferred within 2 weeks after the onset of bacteremia, an informed consent was waived by institutional review board.
Exclusion criteria
Exclusion criteria: Patienst who do not agree the participation in this study, except for patients who fulfill the criteria of a waiver of informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk factor assessment for CA-MRSA - clinical, microbiological characteristics of CA-MRSA bacteremia | — |
Secondary
| Measure | Time frame |
|---|---|
| 30-day mortality | — |
Countries
Korea, Republic of
Contacts
Seoul National University Bundang Hospital